Back to search
Hemolytic Anemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemolytic Anemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemolytic Anemia trials you may qualify forThis study will evaluate the safety and efficacy of tafasitamab in adult participants with primary autoimmune blood cell disorders.
Background: \- Researchers who are studying hairy cell leukemia, and how the disease compares with other disorders, are interested in obtaining additional samp…
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
This prospective mixed-method interview study aims to qualitatively describe the beliefs, attitudes, and informational needs around gene therapy for rare pediat…
This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and bas…
There is limited information on what causes injury to the heart in individuals with Sickle Cell Disease (SCD). Researchers in this study want to see if decrease…
This study is an open-label, single arm, multicenter, roll-over extension study to characterize long-term safety, tolerability and efficacy of iptacopan and to…
Background: Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cells to carry oxygen. Research has shown th…
This study will collect clinical response data on participants who were already treated with eculizumab for at least 26 weeks and who started ravulizumab treatm…